Arizona Department of Health Services Case Definitions for Reportable Communicable Morbidities 2012 TABLE OF CONTENTS Definition of Terms Used in Case Classification .......................................................................................................... 6 Definition of Bi-national Case ............................................................................................................................................. 7 ------------------------------------------------------------------------------------------------------- ............................................... 7 AMEBIASIS ............................................................................................................................................................................. 8 ANTHRAX (β) ......................................................................................................................................................................... 9 ASEPTIC MENINGITIS (viral) ......................................................................................................................................... 11 BASIDIOBOLOMYCOSIS ................................................................................................................................................. 12 BOTULISM, FOODBORNE (β) ....................................................................................................................................... 13 BOTULISM, INFANT (β) .................................................................................................................................................... 14 BOTULISM, WOUND (β) ................................................................................................................................................... 15 BOTULISM, OTHER (β) .................................................................................................................................................... 16 BRUCELLOSIS (β) .............................................................................................................................................................. 17 BURKHOLDERIA MALLEI and B. PSEUDOMALLEI ............................................................................................... 18 CAMPYLOBACTERIOSIS ................................................................................................................................................ 19 CHAGAS DISEASE ............................................................................................................................................................ 20 CHANCROID......................................................................................................................................................................... 21 CHLAMYDIA TRACHOMATIS INFECTION ................................................................................................................ 22 CHOLERA (β) ....................................................................................................................................................................... 24 COCCIDIOIDOMYCOSIS (Valley fever) ...................................................................................................................... 25 COLORADO TICK FEVER ............................................................................................................................................... 26 CONJUNCTIVITIS, ACUTE .............................................................................................................................................. 27 CREUTZFELDT-JAKOB DISEASE................................................................................................................................ 28 CRYPTOSPORIDIOSIS (Cryptosporidium parvum) ................................................................................................. 30 CYCLOSPORAISIS ............................................................................................................................................................ 32 CYSTICERCOSIS ............................................................................................................................................................... 33 DENGUE FEVER (β) .......................................................................................................................................................... 34 DIARRHEA, NAUSEA, OR VOMITING ........................................................................................................................ 36 DIPHTHERIA (β) .................................................................................................................................................................. 37 EHRLICHIOSIS / ANAPLASMOSIS .............................................................................................................................. 39 EMERGING OR EXOTIC DISEASE .............................................................................................................................. 42 ENCEPHALITIS, VIRAL or PARASITIC ....................................................................................................................... 43 ENTEROHEMORRHAGIC ESCHERICHIA COLI ..................................................................................................... 45 ENTEROTOXIGENIC ESCHERICHIA COLI (ETEC)............................................................................................... 47 FOODBORNE DISEASE OUTBREAK ......................................................................................................................... 48 GIARDIASIS .......................................................................................................................................................................... 49 GONORRHEA ...................................................................................................................................................................... 51 HAEMOPHILUS INFLUENZAE ....................................................................................................................................... 52 HANSEN’S DISEASE (LEPROSY) ................................................................................................................................ 53 HANTAVIRUS ....................................................................................................................................................................... 54 HEMOLYTIC UREMIC SYNDROME ............................................................................................................................. 56 HEPATITIS A (β) .................................................................................................................................................................. 58 HEPATITIS B, ACUTE (ß) ................................................................................................................................................ 59 HEPATITIS B, CHRONIC ................................................................................................................................................. 61 HEPATITIS B, PERINATAL- Acquired in the United States or U.S. Territories ............................................... 63 HEPATITIS C, ACUTE (β) ................................................................................................................................................ 64 HEPATITIS C, CHRONIC or past infection ................................................................................................................. 65 HEPATITIS D ........................................................................................................................................................................ 67 HEPATITIS E ........................................................................................................................................................................ 68 HERPES GENITALIS ......................................................................................................................................................... 69 HUMAN IMMUNODEFICIENCY VIRUS (HIV) (β)..................................................................................................... 73 2 ADHS Communicable Disease Case Definitions MARCH 2011 INFLUENZA ........................................................................................................................................................................... 77 INFLUENZA-ASSOCIATED PEDIATRIC MORTALITY .......................................................................................... 78 KAWASAKI SYNDROME .................................................................................................................................................. 79 LEGIONELLOSIS (Legionnaires’ disease) .................................................................................................................. 80 LEPTOSPIROSIS ................................................................................................................................................................ 82 LISTERIOSIS (Listeria monocytogenes) ...................................................................................................................... 83 LYME DISEASE ..................................................................................................................................................................